Cytokine Storm Signature in Patients with Moderate and Severe COVID-19

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Aug 26

PMID 36012146

Authors

Olga Kalinina

Alexey Golovkin

Ekaterina Zaikova

Arthur Aquino

Vadim Bezrukikh

Olesya Melnik

Elena Vasilieva

Tatiana Karonova

Igor Kudryavtsev

Evgeny Shlyakhto

Affiliations

Soon will be listed here.

Abstract

Hypercytokinemia, found in SARS-CoV-2 infection, contributes to multiple organ dysfunctions with acute respiratory distress syndrome, shock etc. The aim of this study was to describe cytokine storm signatures in patients with acute COVID-19 and to investigate their influence on severity of the infection. Plasma levels of 47 cytokines were investigated in 73 patients with moderate and severe COVID-19 (41 and 32, respectively) and 11 healthy donors (HD). The most elevated levels comparing patients and the HD were observed for seven pro-inflammatory cytokines (IL-6, IL-8, IL-15, IL-18, IL-27, IFNγ, TNFα), three chemokines (GROα, IP-10, MIG), two anti-inflammatory cytokines (IL-1RA, IL-10), and two growth factors (G-CSF, M-CSF). The patients with severe disease had significantly higher levels of FGF-2/FGF-basic, IL-1β, and IL-7 compared to the HD. The two groups of patients differed from each other only based on the levels of EGF, eotaxin, and IL-12 p40. Pneumonia lung injury, characterized by computer tomography, positively correlated with levels of EGF, IP-10, MCP-3 levels and negatively with IL-12 p40. Pro-inflammatory factors including IL-6, TNFα, and IP-10 negatively correlated with the frequency of the circulating T-helper17-like cells (Th17-like) and follicular Th cells that are crucial to develop SARS-CoV-2-specific plasma cells and memory B cells. Obtained data on the cytokine levels illustrate their influence on progression and severity of COVID-19.

Citing Articles

Long-term mitochondrial and metabolic impairment in lymphocytes of subjects who recovered after severe COVID-19.

Gomez-Delgado I, Lopez-Pastor A, Gonzalez-Jimenez A, Ramos-Acosta C, Hernandez-Garate Y, Martinez-Micaelo N Cell Biol Toxicol. 2025; 41(1):27.

PMID: 39792183 PMC: 11723900. DOI: 10.1007/s10565-024-09976-0.

Differences in Plasma Extracellular Vesicles of Different Origin in On-Pump Versus Off-Pump Cardiac Surgery.

Aquino A, Abutalimova N, Ma Y, Ismail-Zade I, Grebennik V, Rubinstein A Curr Issues Mol Biol. 2024; 46(11):13058-13077.

PMID: 39590373 PMC: 11593215. DOI: 10.3390/cimb46110779.

Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice.

Carolin A, Yan K, Bishop C, Tang B, Nguyen W, Rawle D PLoS One. 2024; 19(11):e0302344.

PMID: 39531435 PMC: 11556745. DOI: 10.1371/journal.pone.0302344.

COVID-19 inflammatory signature in a Mozambican cohort: unchanged red blood series and reduced levels of IL-6 and other proinflammatory cytokines.

Maphossa V, Guiliche O, Babetine T, Castiano C, Inlamea O, Marengue M BMC Infect Dis. 2024; 24(1):1279.

PMID: 39528988 PMC: 11555969. DOI: 10.1186/s12879-024-10132-6.

T Regulatory Cell Subsets Do Not Restore for One Year After Acute COVID-19.

Aquino A, Zaikova E, Kalinina O, Karonova T, Rubinstein A, Mikhaylova A Int J Mol Sci. 2024; 25(21).

PMID: 39519310 PMC: 11545974. DOI: 10.3390/ijms252111759.

References

Li M, Ching Yeung C, Schooling C . Circulating Cytokines and Coronavirus Disease: A Bi-Directional Mendelian Randomization Study. Front Genet. 2021; 12:680646. PMC: 8215612. DOI: 10.3389/fgene.2021.680646. View

Min C, Cheon S, Ha N, Sohn K, Kim Y, Aigerim A . Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016; 6:25359. PMC: 4857172. DOI: 10.1038/srep25359. View

Ryabkova V, Churilov L, Shoenfeld Y . Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned. Clin Immunol. 2020; 223:108652. PMC: 7832378. DOI: 10.1016/j.clim.2020.108652. View

Okabayashi T, Kariwa H, Yokota S, Iki S, Indoh T, Yokosawa N . Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. J Med Virol. 2006; 78(4):417-24. PMC: 7166776. DOI: 10.1002/jmv.20556. View

Kudryavtsev I, Rubinstein A, Golovkin A, Kalinina O, Vasilyev K, Rudenko L . Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. Viruses. 2022; 14(5). PMC: 9147674. DOI: 10.3390/v14051082. View

Laing A, Lorenc A, Del Molino Del Barrio I, Das A, Fish M, Monin L . A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020; 26(10):1623-1635. DOI: 10.1038/s41591-020-1038-6. View

Gutierrez-Bautista J, Rodriguez-Nicolas A, Rosales-Castillo A, Jimenez P, Garrido F, Anderson P . Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset. Front Immunol. 2020; 11:596553. PMC: 7726249. DOI: 10.3389/fimmu.2020.596553. View

Kuri-Cervantes L, Pampena M, Meng W, Rosenfeld A, Ittner C, Weisman A . Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol. 2020; 5(49). PMC: 7402634. DOI: 10.1126/sciimmunol.abd7114. View

Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033-1034. PMC: 7270045. DOI: 10.1016/S0140-6736(20)30628-0. View

10.

Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W . Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020; 146(1):89-100. PMC: 7212968. DOI: 10.1016/j.jaci.2020.05.003. View

11.

Angioni R, Sanchez-Rodriguez R, Munari F, Bertoldi N, Arcidiacono D, Cavinato S . Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients. Cell Death Dis. 2020; 11(11):957. PMC: 7646225. DOI: 10.1038/s41419-020-03151-z. View

12.

Juno J, Tan H, Lee W, Reynaldi A, Kelly H, Wragg K . Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020; 26(9):1428-1434. DOI: 10.1038/s41591-020-0995-0. View

13.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

14.

Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J . Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005; 171(8):850-7. DOI: 10.1164/rccm.200407-857OC. View

15.

Morita R, Schmitt N, Bentebibel S, Ranganathan R, Bourdery L, Zurawski G . Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011; 34(1):108-21. PMC: 3046815. DOI: 10.1016/j.immuni.2010.12.012. View

16.

Nossent E, Schuurman A, Reijnders T, Saris A, Jongerius I, Blok S . Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients. Front Immunol. 2021; 12:664209. PMC: 8160522. DOI: 10.3389/fimmu.2021.664209. View

17.

Sun D, Zhang D, Tian R, Li Y, Wang Y, Cao J . The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?. Clin Chim Acta. 2020; 508:122-129. PMC: 7224669. DOI: 10.1016/j.cca.2020.05.027. View

18.

Cooper A, Khader S . IL-12p40: an inherently agonistic cytokine. Trends Immunol. 2006; 28(1):33-8. DOI: 10.1016/j.it.2006.11.002. View

19.

Finak G, Langweiler M, Jaimes M, Malek M, Taghiyar J, Korin Y . Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium. Sci Rep. 2016; 6:20686. PMC: 4748244. DOI: 10.1038/srep20686. View

20.

Bentebibel S, Khurana S, Schmitt N, Kurup P, Mueller C, Obermoser G . ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination. Sci Rep. 2016; 6:26494. PMC: 4882544. DOI: 10.1038/srep26494. View